Physical and Psychosocial Parameters in Takayasu Arteritis and Behçet's Disease: A Comparative Study With Healthy Controls
1 other identifier
observational
30
1 country
1
Brief Summary
Systemic vasculitis refers to a group of rare diseases characterized by inflammation of blood vessel walls, which may cause ischemia and structural damage in various organs. Among large-vessel vasculitides, Takayasu arteritis primarily affects the aorta and its main branches, whereas Behçet's disease is a variable vessel vasculitis involving arteries and veins of all sizes. Both conditions can lead to multisystemic involvement and significantly impact physical and psychosocial health. This observational, case-control study aims to compare multiple physical and psychosocial parameters among individuals with Takayasu arteritis, Behçet's disease, and healthy controls. Assessments will include respiratory and peripheral muscle strength, functional status, exercise capacity, body composition, quality of life, illness perception, and psychological well-being. Measurements will be conducted using standardized clinical tests (such as maximal inspiratory and expiratory pressures, handgrip and limb strength dynamometry, squat test, and six-minute walk test) and validated questionnaires (Health Assessment Questionnaire (HAQ), the Short Form-36 Health Survey (SF-36), the EuroQol 5-Dimension 5-Level Questionnaire (EQ-5D-5L), and the Visual Analogue Scale (VAS)). The study seeks to identify differences between groups and provide a comprehensive understanding of how systemic inflammation in Takayasu arteritis and Behçet's disease affects physical performance, quality of life, and psychosocial health. These findings may help guide physiotherapy, rehabilitation, and multidisciplinary management strategies for patients with systemic vasculitis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Sep 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 11, 2025
CompletedFirst Submitted
Initial submission to the registry
November 18, 2025
CompletedFirst Posted
Study publicly available on registry
December 10, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
January 30, 2026
CompletedDecember 10, 2025
October 1, 2025
4 months
November 18, 2025
December 9, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Peripheral muscle strength
Peripheral muscle strength will be assessed using the Commander Echo™ Muscle Testing Dynamometer (JTECH Medical, USA) for upper and lower extremities. Measurements will include quadriceps, biceps, and shoulder abductor muscle strength. The average of three trials will be recorded in kilograms.
Single assessment (baseline only)
Respiratory Muscle Strength
Measured by maximal inspiratory pressure (MIP) and maximal expiratory pressure (MEP) using a portable electronic manometer (Micro Medical MicroMPM, UK).
Single assessment (baseline only)
Secondary Outcomes (9)
Functional Exercise Capacity-Six-Minute Walk Test (6MWT)
Single session at baseline
Functional Status- Health Assessment Questionnaire
Single session at baseline
General Health Perception - Visual Analogue Scale (VAS)
Single assessment at baseline.
Quality of Life - Short Form-36 Health Survey (SF-36)
Single session at baseline
Quality of Life - EuroQol 5-Dimension 5-Level Questionnaire (EQ-5D-5L)
Single session at baseline.
- +4 more secondary outcomes
Study Arms (3)
Takayasu Arteritis Group
Participants diagnosed with Takayasu arteritis according to established clinical and imaging criteria.
Behçet's Disease Group
Participants diagnosed with Behçet's disease according to the International Study Group criteria.
Healthy Control Group
Age- and sex-matched healthy volunteers with no systemic or chronic disease.
Interventions
Participants will not receive any treatment or intervention. The study involves only physical and psychosocial assessments and questionnaires.
Eligibility Criteria
The study population will consist of individuals aged 18 years and older who have been diagnosed with Takayasu arteritis or Behçet's disease and are being followed at the Rheumatology Department of Pamukkale University, as well as age- and sex-matched healthy volunteers without systemic, neurological, or musculoskeletal disease. All participants will provide written informed consent prior to inclusion in the study.
You may qualify if:
- Age 18 years or older.
- Diagnosis of Takayasu arteritis according to the American College of Rheumatology (ACR) classification criteria.
- Voluntary participation with written informed consent.
- Age 18 years or older.
- Diagnosis of Behçet's disease according to the International Study Group for Behçet's Disease criteria.
- Voluntary participation with written informed consent.
- Age 18 years or older.
- No history of systemic, rheumatologic, or chronic inflammatory disease.
- Voluntary participation with written informed consent.
You may not qualify if:
- Pregnancy.
- Presence of psychiatric disorder or ongoing psychiatric treatment.
- Cognitive impairment that may interfere with participation.
- Presence of neurological disease (e.g., hemiplegia, Parkinson's disease, multiple sclerosis, vertigo, epilepsy, etc.).
- History of any surgical operation within the past year.
- Coexisting rheumatic disease other than Takayasu arteritis or Behçet's disease.
- Pregnancy.
- Presence of psychiatric disorder or ongoing psychiatric treatment.
- Cognitive impairment that may interfere with participation.
- Presence of neurological disease (e.g., hemiplegia, Parkinson's disease, multiple sclerosis, vertigo, epilepsy, etc.).
- History of any surgical operation within the past year.
- History of rheumatologic or chronic inflammatory disease.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- ÖZLEM NUR TOK YAMANlead
- Pamukkale Universitycollaborator
- Uşak Universitycollaborator
- Alanya Alaaddin Keykubat Universitycollaborator
Study Sites (1)
Pamukkale University
Denizli, Denizli, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Lecturer , Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation
Study Record Dates
First Submitted
November 18, 2025
First Posted
December 10, 2025
Study Start
September 11, 2025
Primary Completion
December 30, 2025
Study Completion
January 30, 2026
Last Updated
December 10, 2025
Record last verified: 2025-10